A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS

Oropharyngeal candidiasis is the most common opportunistic infection among persons infected with human immunodeficiency virus (HIV). Use of some agents is hampered by lack of efficacy, emergence of resistance, adverse events, and need for intravenous administration. Posaconazole is an extended-spect...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical infectious diseases Vol. 42; no. 8; p. 1179
Main Authors:	Vazquez, Jose A, Skiest, Daniel J, Nieto, Leopoldo, Northland, Rebeca, Sanne, Ian, Gogate, Jagadish, Greaves, Wayne, Isaacs, Randi
Format:	Journal Article
Language:	English
Published:	United States 15.04.2006
Subjects:	Adult Aged AIDS-Related Opportunistic Infections - drug therapy Antifungal Agents - therapeutic use Candida - classification Candida - isolation & purification Candidiasis - drug therapy Candidiasis, Oral - drug therapy Double-Blind Method Ethnic Groups Female Fluconazole - therapeutic use Humans Male Microbial Sensitivity Tests Middle Aged Pharyngeal Diseases - drug therapy Pharyngeal Diseases - microbiology Probability Treatment Outcome Triazoles - pharmacology Triazoles - therapeutic use
ISSN:	1537-6591, 1537-6591
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!